Furthermore, MSH2 expression was found to be associated with high TMB, increased PD-L1 expression and CD8+ T cells infiltration in lung adenocarcinoma (LUAD) patients with ICIs, suggesting MSH2 as a potential predictive biomarker 54. The gene discussed is CD274; the disease is lung adenocarcinoma.